GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mural Oncology PLC (NAS:MURA) » Definitions » PB Ratio

Mural Oncology (Mural Oncology) PB Ratio : 0.23 (As of Jun. 22, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mural Oncology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-22), Mural Oncology's share price is $3.23. Mural Oncology's Book Value per Share for the quarter that ended in Mar. 2024 was $13.88. Hence, Mural Oncology's PB Ratio of today is 0.23.

The historical rank and industry rank for Mural Oncology's PB Ratio or its related term are showing as below:

MURA' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.31
Current: 0.23

During the past 3 years, Mural Oncology's highest PB Ratio was 0.31. The lowest was 0.00. And the median was 0.00.

MURA's PB Ratio is ranked better than
97.69% of 1300 companies
in the Biotechnology industry
Industry Median: 2.345 vs MURA: 0.23

Back to Basics: PB Ratio


Mural Oncology PB Ratio Historical Data

The historical data trend for Mural Oncology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mural Oncology PB Ratio Chart

Mural Oncology Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- - 0.37

Mural Oncology Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only - - - 0.37 0.35

Competitive Comparison of Mural Oncology's PB Ratio

For the Biotechnology subindustry, Mural Oncology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mural Oncology's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mural Oncology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Mural Oncology's PB Ratio falls into.



Mural Oncology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Mural Oncology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=3.23/13.882
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Mural Oncology  (NAS:MURA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Mural Oncology PB Ratio Related Terms

Thank you for viewing the detailed overview of Mural Oncology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mural Oncology (Mural Oncology) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
10 Earlsfort Terrace, Dublin, IRL, D02 T380
Website
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging their core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. The Company operates as one business segment, which is the business of developing medicines designed to address unmet medical needs of patients in the area of oncology.

Mural Oncology (Mural Oncology) Headlines